Literature DB >> 23445246

Histological findings on jaw osteonecrosis associated with bisphosphonates (BONJ) or with radiotherapy (ORN) in humans.

Daniela Carmagnola1, Elena Canciani, Davide Sozzi, Federico Biglioli, Laura Moneghini, Claudia Dellavia.   

Abstract

OBJECTIVE: To describe the histological features of bone tissue harvested from patients affected by jaw osteonecrosis associated with bisphoshponates (BONJ) or with radiotherapy (ORN), in undecalcified ground sections.
MATERIALS AND METHODS: Sixteen bone tissue samples from 14 patients with BONJ and two patients with ORN were processed in order to obtain both ground, undecalcified sections and decalcified sections. The sections underwent histometric and morphometric analysis.
RESULTS: Bone tissue samples obtained from patients with BONJ or ORN of the jaws shared some histological characteristics. Common histological features included the loss of bone architecture, the absence of a proper Haversian system and proper marrow spaces, the presence of necrotic spots of non-mineralized tissue, areas of empty osteocytic lacunae next to areas of hypercellularity, the presence of resorption pits with rare osteoclast-like cells and the presence of bacteria and of an inflammatory infiltrate. A violet rib of tissue characterized by large resorption pits facing was frequently observed between the mineralized bone and the inflammatory infiltrate.
CONCLUSIONS: The histological features of BONJ and ORN are similar and resemble those of osteomyelitis. Even though it is not clear whether infection is the cause or consequence of bone exposure, inflammatory cells, bacteria or their products may have a massive, direct lytic effect on bone tissue challenged by bisphosphonates.

Entities:  

Mesh:

Year:  2013        PMID: 23445246     DOI: 10.3109/00016357.2013.765592

Source DB:  PubMed          Journal:  Acta Odontol Scand        ISSN: 0001-6357            Impact factor:   2.331


  6 in total

1.  Zoledronate but not denosumab suppresses macrophagic differentiation of THP-1 cells. An aetiologic model of bisphosphonate-related osteonecrosis of the jaw (BRONJ).

Authors:  Sebastian Hoefert; Claudia Sade Hoefert; Marc Albert; Adelheid Munz; Martin Grimm; Hinnak Northoff; Siegmar Reinert; Dorothea Alexander
Journal:  Clin Oral Investig       Date:  2014-11-21       Impact factor: 3.573

2.  Bisphosphonate-related osteonecrosis induced change in alveolar bone architecture in rats with participation of Wnt signaling.

Authors:  Vanessa Costa de Sousa Ferreira; Amanda Pimentel Lopes; Nicholas Militão Alves; Fatima Regina Nunes Sousa; Karuza Maria Alves Pereira; Delane Viana Gondim; Vírginia Claúdia Carneiro Girão; Renata Ferreira Carvalho Leitão; Paula Goes
Journal:  Clin Oral Investig       Date:  2020-09-08       Impact factor: 3.573

3.  Antiresorptive drug-related changes of the mandibular bone densitiy in medication-related osteonecrosis of the jaw patients.

Authors:  Nils Heim; Werner Götz; Franz-Josef Kramer; Anton Faron
Journal:  Dentomaxillofac Radiol       Date:  2019-09-17       Impact factor: 2.419

4.  Adalimumab: Another Medication Related to Osteonecrosis of the Jaws?

Authors:  Andrea Cassoni; Umberto Romeo; Valentina Terenzi; Marco Della Monaca; Oriana Rajabtork Zadeh; Ingrid Raponi; Maria Teresa Fadda; Antonella Polimeni; Valentino Valentini
Journal:  Case Rep Dent       Date:  2016-03-21

5.  Extensive protein expression changes induced by pamidronate in RAW 264.7 cells as determined by IP-HPLC.

Authors:  Sang Shin Lee; Soung Min Kim; Yeon Sook Kim; Suk Keun Lee
Journal:  PeerJ       Date:  2020-05-21       Impact factor: 2.984

6.  Osteonecrosis of the Jaw Beyond Bisphosphonates: Are There Any Unknown Local Risk Factors?

Authors:  Johann Lechner; Volker von Baehr; Bernd Zimmermann
Journal:  Clin Cosmet Investig Dent       Date:  2021-01-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.